Most are familiar with the name Moderna and its landmark role in developing one of the first COVID-19 vaccines, but few know how the company leveraged AI to accelerate its creation. Today, Moderna’s Director of AI and Data Science, Dr. Andrew Giessel, joins us on The ConversAItion to discuss how his team leverages AI to accelerate the mRNA research process for a number of different applications, the importance of training employees in AI basics and how computer science and biology can work hand-in-hand in the future to transform the pharmaceutical industry. You can find Andrew on Twitter @giessel.
Connect with listeners
Podcasters use the RadioPublic listener relationship platform to build lasting connections with fansYes, let's begin connecting
Find new listeners
Understand your audience
Engage your fanbase